International study challenges age-based treatment decisions in leukemia

An international study conducted by the Alliance for Clinical Trials in Oncology and the Acute Myeloid Leukemia Cooperative Group reveals that age-based classifications in the treatment of acute myeloid leukemia (AML) may be outdated and overly simplistic.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup